Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
x24d1124tNwsE53Z